SNK-396is under clinical development by Synerk and currently in Phase I for Lipi...
IN-14199is under clinical development by HK inno.N and currently in Phase I for ...
New data shows that among adults under the age of 40, only 1 in 4 people with he...
Alkermes shareholders voted to re-elect all of the drugmaker’s current directors...
A former Pfizer statistician was charged by U.S. authorities with insider tradin...
The U.S. Supreme Court struck down the use of affirmative action, ruling that it...
The owner of a pharmaceutical wholesaler has been indicted for his alleged role ...
The case turned on claims that a deal Gilead and Teva reached to end patent liti...
Some medical school and educational leaders are hopeful that a path exists to di...
Five cases of malaria have been diagnosed in Florida and Texas in recent weeks —...
Currently, just 5.7% of doctors in the U.S. are Black and 7% are Hispanic. Those...
Bright Health is officially leaving the health insurance market. The company has...
The FDA approved a BioMarin Pharmaceutical gene therapy for people with hemophil...
Medicare on Friday released new details about how its new drug price negotiation...
Breast reconstruction is a deeply personal issue, and patients should be able to...
The approval of Sarepta Therapeutics’ gene therapy, Elevidys, is an ecstatic mom...
